NEW ON THE MARKET
COVID-19 vaccine from AstraZeneca
Inclisiran (LEQVIO): lower cholesterol with an injection every 6 months?
THERAPY FROM A CRITICAL VIEWPOINT
ACE inhibitors and angiotensin II antagonists: withdrawal without influence on the course of COVID-19
IN BRIEF
Risks of the appetite suppressant amfepramone to be reassessed
SIDE EFFECTS
Gyrase inhibitors: risk of aneurysms not just for risk groups free article
Increased risk of cancer with the JAK inhibitor tofacitinib (XELJANZ)
e a-t ON THE INTERNET
Bamlanivimab against COVID-19